Articles

Highlights of the Gastrointestinal Cancers Symposium 2018

BJMO - volume 12, issue 3, may 2018

W. Lybaert MD, I. Dero MD, M. Peeters MD, PhD

With the background of the famous Golden Gate Bridge and Alcatraz, the annual Gastrointestinal Cancers Symposium was held from 18–20 January 2018 in the Moscone Congress Center in San Francisco, California. In this report, the most important headlines will be discussed, with comments on the clinical relevance of the different studies.

(BELG J MED ONCOL 2018:12(3):133–141)

Read more

Highlights in gastrointestinal oncology

BJMO - volume 11, issue 7, november 2017

L. Triest MD, K. Papadimitriou MD, PhD, M. Rasschaert MD, PhD, J. Van den Brande MD, M. Peeters MD, PhD

ESMO 2017 featured the presentation of several practice changing data in the field of gastrointestinal (GI) cancer. The first part of this report will summarize the key data presented in the field of gastric cancer, gastroesophageal junction (GEJ), biliary, gallbladder, biliary, pancreatic and hepatocellular cancer. In the second part, the focus is turned to colorectal cancer.

(BELG J ONCOL 2017;11(7):340–348)

Read more

Highlights in gastrointestinal cancers

BJMO - volume 11, issue 4, september 2017

K. Papadimitriou MD, PhD, M. Rasschaert MD, PhD, J. Van den Brande MD, M. Peeters MD, PhD

The 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) took place once more in Chicago from June 2 to 6, bringing together more than 30,000 oncology professionals from around the world. This year’s meeting theme is “Making a Difference in Cancer Care with You.” Studies spanning the spectrum of GI cancer prevention and care, from new standards of care to immunotherapy and precision medicine, will be highlighted.

Read more

Highlights of the European Neuroendocrine Tumor Society (ENETS) Congress

BJMO - volume 11, issue 3, may 2017

W. Lybaert MD, M. Simoens , Wim Demey MD, F. van Fraeyenhove MD, T. Vandamme MD, PhD, L. De Backer , M. Peeters MD, PhD

Barcelona, 8-10 March 2017.

(BELG J MED ONCOL 2017;11(3):129–133)

Read more

O.08 Evaluation of HER2 expression and amplification in CTCs using CellSearch immunofluorescence and FISH

BJMO - 2017, issue 3, february 2017

A. Brouwer , P-J. Van Dam MD, E. Sluydts , M. Peeters MD, PhD, P. Vermeulen MD, S. Van Laere PhD, L. Dirix MD

Read more

P.03 Selective internal radiotherapy: a 5-year single-center experience

BJMO - 2017, issue 3, february 2017

T. Van den Mooter MD, S. Van Hecke , I. Huyghe , T. Chapelle , M. Peeters MD, PhD

Read more

P.08 A prospective study on the impact of a NET specific multidisciplinary tumor board on individual treatment plans

BJMO - 2017, issue 3, february 2017

W. Lybaert MD, T. Vandamme MD, PhD, M. Simoens , I. Dero MD, Wim Demey MD, T. Rondou , A. Cuypers , P. Abrams , C. Mattelaer , A. Driessen MD, PhD, B. Op de Beeck , O. D’Archambeau , G. Roeyen MD, PhD, L. De Backer , M. Peeters MD, PhD, NET specialists NETwerk Steering Committee

Read more